Andrew Tingey is a leading IP strategist with over 20 years’ experience in a variety of commercial roles centred around licensing and other IP-based transactions.
Andrew holds a first-class honours degree in Biochemistry from the University of York, a PhD in Biochemistry from the University of Leicester, and a triple-accredited MBA from the Open University Business School. Andrew has also held Certified Licensing Professional accreditation since 2012.
Andrew has a real “hands-on” experience of dealmaking in hundreds of IP-based transactions from the perspectives of big corporate, venture capital and top-tier technology transfer offices. Andrew has successfully completed several IP transaction projects for clients in multiple sectors, including in and out licensing, with an emphasis on valuation and determination of acceptable deal terms.
Andrew was previously head of technology transfer for Imperial College London, overseeing the formation of dozens of start-up companies and the completion of over 300 licence agreements. He has also held roles as Senior Director, Licensing & IP Strategy at Eagle Genomics, Director of Licensing at Royal DSM NV, as well as senior roles in a leading CRO (Contract Research Organisation).
Andrew provides advice on the commercial aspects of licensing, buying, and selling intellectual property in all its forms, ranging from structuring licence deals to advising on IP terms in partnering agreements and valuing intellectual property for balance sheets or transactions. He also provides advice on technology transfer operations and strategy along with IP-related competitive intelligence and strategy.
Andrew’s work involves the valuation of intellectual property based on robust methodology and meaningful assumptions. He drafts term sheets and translates IP valuations into deal terms that deliver value to clients. Andrew also advises on negotiation positions and strategy to guide clients through the licensing process and help clients determine market-reasonable or typical deal terms for their technology.
Andrew also works on the design of strategic and operational initiatives in technology transfer, offering clients workable and pragmatic strategies to achieve their objectives.
Andrew is particularly experienced in licensing and IP valuation, having led or overseen hundreds of licensing transactions in multiple sectors and industries, ranging from universities to very large corporate entities. This experience means that he can apply efficient, logical, and practical perspectives to client’s licensing issues.